MXPA00002462A - Formulacion de vitamina para la salud cardiovascular. - Google Patents

Formulacion de vitamina para la salud cardiovascular.

Info

Publication number
MXPA00002462A
MXPA00002462A MXPA00002462A MXPA00002462A MXPA00002462A MX PA00002462 A MXPA00002462 A MX PA00002462A MX PA00002462 A MXPA00002462 A MX PA00002462A MX PA00002462 A MXPA00002462 A MX PA00002462A MX PA00002462 A MXPA00002462 A MX PA00002462A
Authority
MX
Mexico
Prior art keywords
cardiovascular health
vitamin
composition
high level
vitamin formulation
Prior art date
Application number
MXPA00002462A
Other languages
English (en)
Inventor
Stillman Robert
Original Assignee
Bristol Myers Sq Ibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Sq Ibb Company filed Critical Bristol Myers Sq Ibb Company
Publication of MXPA00002462A publication Critical patent/MXPA00002462A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion se relaciona a una composicion que contiene un alto nivel de vitamina E y un alto nivel de silicatos. La composicion se puede comprimir en tabletas o capsulillas que no exuden la vitamina E durante la compresion y/o almacenamiento. La composicion de preferencia contiene vitaminas y minerales en dosis optimizadas para la salud cardiovascular.
MXPA00002462A 1999-03-18 2000-03-10 Formulacion de vitamina para la salud cardiovascular. MXPA00002462A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27181099A 1999-03-18 1999-03-18

Publications (1)

Publication Number Publication Date
MXPA00002462A true MXPA00002462A (es) 2004-10-28

Family

ID=35744572

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA00002462A MXPA00002462A (es) 1999-03-18 2000-03-10 Formulacion de vitamina para la salud cardiovascular.

Country Status (1)

Country Link
MX (1) MXPA00002462A (es)

Similar Documents

Publication Publication Date Title
WO2003059274A3 (en) Vitamin formulation for cardiovascular health
PT1578406E (pt) Composição farmacêutica de libertação modificada
AU2003274681A8 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
NZ507271A (en) Fast disintegrating tablets
CA2284663A1 (en) Rapidly dissolving robust dosage form
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
HUP0003990A3 (en) Methods of treating capsules and dry, powdered pharmaceutical formulations
EP1066761A3 (en) Compositions containing fat-soluble substances in a carbohydrate matrix
EP1075836A3 (en) Skin care of food composition containing N-acetyl-glucosamine
GB2138290B (en) Divisible polyacrylate-based tablet
EP1036510A3 (en) Vitamin formulation for cardiovascular health
ATE243504T1 (de) Cefadroxilmonohydrat tablettenformulierung
WO2002055093A3 (en) Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages
HK1067299A1 (en) Pharmaceutical compositions containing terbinafineand use thereof
WO2005007137A3 (de) Ambroxolhaltige tabletten
AR024564A1 (es) Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
GB0228354D0 (en) Detergent compositions
MXPA00002462A (es) Formulacion de vitamina para la salud cardiovascular.
GB2295966B (en) Direct compression tablets
PL350908A1 (en) Granulate with high content of l−carnitine or an alkanoyl l−carnitine
HUP0203118A3 (en) Beta disubstituted metalloprotease inhibitors, pharmaceutical compositions containing them and their use
AP2000001914A0 (en) Paroxetine compositions.
MXPA04006054A (es) Composicion farmaceutica oral para capsulas blandas que contienen vinorelbine y metodo de tratamiento.